Gender differences in retention rate of tumor necrosis factor alpha inhibitor treatment in ankylosing spondylitis: a retrospective cohort study in daily practice-Reference-Cited by-同舟云学术

Gender differences in retention rate of tumor necrosis factor alpha inhibitor treatment in ankylosing spondylitis: a retrospective cohort study in daily practice

Published:2018-04 Issue:4 Volume:21 Page:836-842
ISSN:1756-1841
Container-title:International Journal of Rheumatic Diseases
language:en
Short-container-title:Int J Rheum Dis

Author:

Rusman Tamara¹^ORCID,ten Wolde Saskia²,Euser Sjoerd M.³⁴,van der Ploeg Tjeerd⁵⁴,van Hall Odile⁶,van der Horst-Bruinsma Irene E.¹

Affiliation:

1. Amsterdam Rheumatology and Immunology Center; Department of Rheumatology; VU University Medical Center; Amsterdam The Netherlands

2. Spaarne Gasthuis Haarlem; Haarlem The Netherlands

3. Regional Laboratory of Public Health; Kennemerland Haarlem; Haarlem The Netherlands

4. Spaarne Gasthuis Academie; Haarlem The Netherlands

5. Spaarne Medical Centre Alkmaar; Haarlem The Netherlands

6. Slotervaart Hospital; Amsterdam The Netherlands

Publisher

Wiley

Subject

Rheumatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/1756-185X.13271/fullpdf

Reference38 articles.

1. Striking prevalence of ankylosing spondylitis in “healthy” w27 positive males and females;Calin;N Engl J Med,1975

2. Is there sexual inequality in ankylosing spondylitis? A study of 498 women and 1202 men;Will;J Rheumatol,1990

3. Ankylosing spondylitis;Braun;Lancet,2007

4. Treatment of ankylosing spondylitis with disease modifying antirheumatic drugs;van der Horst-Bruinsma;Clin Exp Rheumatol,2002

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Disproportional signal of pericarditis with biological diseasemodifying antirheumatic drugs (bDMARDs) in patients with ankylosing spondylitis: a disproportionality analysis in the FAERS database;Frontiers in Pharmacology;2024-01-25

2. Retention rate of subcutaneous TNF inhibitors in axial spondyloarthritis in a multicentre study from the RIC-FRANCE network;Scientific Reports;2024-01-16

3. Sex differences in the effectiveness of first-line tumour necrosis factor inhibitors in axial spondyloarthritis: results from the EuroSpA Research Collaboration Network;RMD Open;2023-12

4. Sex-oriented perspectives in immunopharmacology;Pharmacological Research;2023-11

5. Incidence of infections in patients with psoriatic arthritis and axial spondyloarthritis treated with biological or targeted disease-modifying agents: a systematic review and meta-analysis of randomised controlled trials, open-label studies and observational studies;RMD Open;2023-09